Skip to content

Clinical trials

Hyperphosphatemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20162
20171
20181
20193
20203
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alebund Pharmaceuticals3
Huashan Hospital2
Chen Jing1
Grand Life Science (Liaoning) Co., Ltd.1
Jemincare1
Jiujiang No.1 People's Hospital1
Limeng Chen1
Panion & BF Biotech Inc.1
R1 Therapeutics1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia17
Renal Insufficiency, Chronic6
Kidney Failure, Chronic3
Chronic Kidney Disease-Mineral and Bone Disorder1
Hyperparathyroidism, Secondary1
Hypocalcemia1
Kidney Diseases1
Phosphorus Metabolism Disorders1
Renal Insufficiency1

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.